Two years on: progression free survival analysis of patients with advanced small cell lung cancer receiving atezolizumab plus etoposide and carboplatin in a tertiary oncology centre

Burney, R., Narayanaswamy, V., Bates, E. et al. (7 more authors) (2023) Two years on: progression free survival analysis of patients with advanced small cell lung cancer receiving atezolizumab plus etoposide and carboplatin in a tertiary oncology centre. In: Lung Cancer. 21st Annual British Thoracic Oncology, 26-28 Apr 2023, Belfast, Northern Ireland. Elsevier

Metadata

Item Type:	Proceedings Paper
Authors/Creators:	Burney, R. Narayanaswamy, V. Bates, E. Das, T. Danson, S. https://orcid.org/0000-0002-3593-2890 Fisher, P. Hatton, M. https://orcid.org/0000-0003-2778-7926 Taylor, F. Young, R. Lee, C. https://orcid.org/0000-0003-0322-3229
Copyright, Publisher and Additional Information:	© 2023 Elsevier B.V.
Keywords:	Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Cancer; Rare Diseases; Lung; Lung Cancer; Cancer
Dates:	Published: April 2023
Institution:	The University of Sheffield
Academic Units:	The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health The University of Sheffield > Sheffield Teaching Hospitals
Depositing User:	Symplectic Sheffield
Date Deposited:	28 Aug 2024 15:35
Last Modified:	28 Aug 2024 15:41
Status:	Published
Publisher:	Elsevier
Refereed:	Yes
Identification Number:	10.1016/s0169-5002(23)00595-0
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:216454

CORE (COnnecting REpositories)

Two years on: progression free survival analysis of patients with advanced small cell lung cancer receiving atezolizumab plus etoposide and carboplatin in a tertiary oncology centre

Metadata

Download not available

Export

Statistics